呼吸努力监测:一种新颖的床旁无创实时方法
该研究开发并验证了一种基于呼吸系统运动方程的无创实时呼吸肌压力监测算法(N-Pmus)。台架研究使用ASL5000模拟器在270种临床场景中验证,N-Pmus与ASL5000-Pmus的边际R²=0.993,条件R²=0.997,偏差-0.23 cmH₂O,一致性限-1.51至1.04 cmH₂O。前瞻性观察性临床验证(n=23)比较N-Pmus与同步食管压推导的Pmuseso,边际R²=0.97,条件R²=0.971,偏差-0.2 cmH₂O,一致性限-2.22至1.83 cmH₂O。该无创方法可能为床旁监测呼吸努力提供新工具。
要点
- 台架研究显示N-Pmus与ASL5000-Pmus高度相关:边际R²=0.993,条件R²=0.997,偏差-0.23 cmH₂O,一致性限-1.51至1.04 cmH₂O。
- 临床验证(n=23)中N-Pmus与Pmuseso一致性良好:边际R²=0.97,条件R²=0.971,偏差-0.2 cmH₂O,一致性限-2.22至1.83 cmH₂O。
- N-Pmus为无创、实时监测呼吸肌压力的方法,基于呼吸系统运动方程开发,旨在克服现有呼吸努力监测方法的侵入性和复杂性挑战。
- 研究为前瞻性观察性设计,样本量23例,台架研究覆盖270种临床场景,结果支持N-Pmus作为呼吸努力监测的潜在床旁工具。
适用人群与场景
- 接受机械通气的呼吸衰竭患者(临床验证纳入23例,前瞻性观察性研究)。
研究设计与关键结果
- 研究类型:台架研究加前瞻性观察性临床验证;台架研究使用ASL5000模拟器在270种临床场景中验证N-Pmus算法,临床验证n=23,比较N-Pmus与同步食管压推导的Pmuseso。
- 台架研究结果:N-Pmus与ASL5000-Pmus的边际R²=0.993,条件R²=0.997,偏差-0.23 cmH₂O,一致性限-1.51至1.04 cmH₂O。
- 临床验证结果:N-Pmus与Pmuseso的边际R²=0.97,条件R²=0.971,偏差-0.2 cmH₂O,一致性限-2.22至1.83 cmH₂O。
- N-Pmus与已建立的Pmus基准的关联使用线性混合效应模型分析,偏差和一致性通过重复测量的Bland-Altman分析评估。
证据类型、等级与局限
- 证据类型:台架验证研究加前瞻性观察性临床验证(n=23)。
- 局限:原文未报告局限性。
对床旁实践的改变
- N-Pmus作为一种无创、实时呼吸肌压力监测方法,在台架和临床验证中与参考方法显示高度相关和良好一致性,可能为床旁呼吸努力监测提供无创替代途径。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Mechanical ventilation is essential for treating respiratory failure. However, ventilator over-assistance can lead to ventilator-induced diaphragm dysfunction (VIDD), and insufficient assistance can necessitate excessive effort, which leads to high stress and damage diaphragm function. Current methods monitoring respiratory effort face clinical implementation challenges due to invasiveness and complexity. This study introduces and validates a novel non-invasive real-time respiratory muscle pressure (N-Pmus) monitoring method.
METHODS: (1) The bench study involved developing a non-invasive, real-time respiratory muscle pressure monitoring algorithm (N-Pmus) based on the equation of motion of the respiratory system and validated with efforts generated by the ASL simulator (ASL5000-Pmus) across 270 clinical scenarios. (2) A clinical validation was performed through a prospective observational study (n = 23), comparing N-Pmus with the Pmus derived from simultaneously monitored esophageal pressure (Pmuseso) to assess correlation and agreement. The association between N-Pmus and the established Pmus benchmarks was analyzed using linear mixed-effects models. Bias and agreement were evaluated through Bland-Altman analysis for repeated measures.
RESULTS: (1) The bench study demonstrated that N-Pmus correlated well with ASL5000-Pmus, with marginal R²=0.993 and conditional R²=0.997. The bias was - 0.23 cmH₂O, with limits of agreement ranging from - 1.51 to 1.04 cmH₂O. (2) The clinical validation revealed strong N-Pmus/Pmuseso agreement with marginal R²=0.97 and conditional R²=0.971. The bias was - 0.2 cmH₂O, with limits of agreement ranging from - 2.22 to 1.83 cmH₂O.
CLINICAL TRIAL NUMBER: Retrospectively registered with https://www.chictr.org.cn/ .
REGISTRATION NUMBER: ChiCTR2300076940, registered 24 October 2023.
参考来源
- Lv Y, Dong M, Song H, et al. Respiratory effort monitoring: a novel, bedside, non-invasive, real-time method. Crit Care. 2025. PMID: 40611271. doi:10.1186/s13054-025-05514-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。